loading page

Prophylactic Negative Pressure Wound Therapy for Cannula Sites of Extracorporeal Biventricular Assist Devices
  • +7
  • Yoshiyuki Takami,
  • Shin-ichi Tanida,
  • Naoki Hoshino,
  • Yusuke Sakurai,
  • Kentaro Amano,
  • Kiyotoshi Akita,
  • Ryosuke Hayashi,
  • Atsuo Maekawa,
  • Hideo Izawa,
  • Yasushi Takagi
Yoshiyuki Takami
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Shin-ichi Tanida
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Naoki Hoshino
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Yusuke Sakurai
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Kentaro Amano
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Kiyotoshi Akita
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Ryosuke Hayashi
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Atsuo Maekawa
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Hideo Izawa
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile
Yasushi Takagi
Fujita Health University School of Medicine Graduate School of Medicine
Author Profile

Abstract

We report wound management using a vacuum-assisted closure (VAC) system for the cannula sites of long-term extracorporeal biventricular assist devices (BiVADs). A 23-year old Chinese female patient with a diagnosis of giant cell myocarditis needed extracorporeal BiVADs for more than 9 months. When the cannula sites appeared necrotic 3 months after BiVADs placement, she underwent negative pressure wound therapy prophylactically for four cannula sites, using a VAC system for 3 months, followed by no infections. Such prophylactic VAC therapy may be useful to avoid cannula site infections, which is still a fatal adverse event causing sepsis, especially in patients with extracorporeal BiVADs.